The ASX 50 index is home to many of the highest quality companies that the Australian share market has to offer.
And while not all shares in the index are necessarily in the buy zone right now, two that could be are listed below.
Here's why analysts rate these ASX 50 shares as buys:
CSL Limited (ASX: CSL)
The first ASX 50 share to consider is CSL. It is one of the world's leading biotechnology companies, comprising the CSL Behring, CSL Vifor, and Seqirus businesses.
As well as having a portfolio filled to the brim with high quality therapies, CSL invests 10%-11% of its sales back into research and development activities each year. This ensures that the company has a large number of potentially lucrative therapies under development, supporting its future growth.
Citi is positive on CSL and currently has a buy rating and $340.00 price target on its shares.
Telstra Corporation Ltd (ASX: TLS)
Another ASX 50 share that is rated highly is telco giant Telstra.
For some time, this telco giant was going backwards with its earnings. However, thanks to the success of its T22 strategy, Telstra returned to underlying growth at long last in FY 2022. And with its new strategy aiming to deliver strong and sustainable earnings growth over the coming years, Telstra's outlook is arguably the best it has been in over a decade.
Morgans is positive on the company and believes that its shares are undervalued at the current level. Especially given its restructure, which aims to unlock value from its assets.
Morgans currently has an add rating and $4.60 price target on Telstra's shares.
